Category : Search result: JioHotstar Pharma series


Sudeep Pharma IPO: 22% GMP, Opens Nov 21

Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.

New Tamil & Telugu OTT Releases: Nov 17-23

Explore this week's Tamil and Telugu OTT releases including Bison on Netflix, Nadu Center on JioHotstar, and The Family Man Season 3 on Amazon Prime Video. Stream now!

AI Mahabharat Review: Storytelling Needs Humans

JioHotstar's AI-generated Mahabharat: Ek Dharmayudh hits 26.5M views but lacks emotional depth. Expert analysis reveals why human storytelling remains irreplaceable in epic adaptations.

European Pharma Stocks Rebound from AI Shift

European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.

Purdue Pharma $7B Opioid Settlement Gets Court Nod

Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.

Jonas Brothers Christmas Film Premieres in India

The Jonas Brothers' holiday film 'A Very Jonas Christmas' releases today on JioHotstar in India. Featuring Priyanka Chopra Jonas and new songs, it's perfect festive entertainment.

Lincoln Pharma Aims for Rs 1000 Crore Revenue

Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.

Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook

Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.

AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion

British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.

Page 3 of 4